The DOI matches its Crossref record; 85 of the 88 references it cites were found in a registry or an index.
International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer
Open accessAbstract
Background: Screening individuals at increased risk for pancreatic cancer (PC) detects early, potentially curable, pancreatic neoplasia. Objective: To develop consortium statements on screening, surveillance and management of high-risk individuals with an inherited predisposition to PC. Methods: A 49-expert multidisciplinary international consortium met to discuss pancreatic screening and vote on statements. Consensus was considered reached if ≥75% agreed or disagreed. Results: There was excellent agreement that, to be successful, a screening programme should detect and treat T1N0M0 margin-negative PC and high-grade dysplastic precursor lesions (pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasm). It was agreed that the following were candidates for screening: first-degree relatives (FDRs) of patients with PC from a familial PC kindred with at least two affected FDRs; patients with Peutz–Jeghers syndrome; and p16 , BRCA 2 and hereditary non-polyposis colorectal cancer (HNPCC) mutation carriers with ≥1 affected FDR. Consensus was not reached for the age to initiate screening or stop surveillance. It was agreed that initial screening should include endoscopic ultrasonography (EUS) and/or MRI/magnetic resonance cholangiopancreatography not CT or endoscopic retrograde cholangiopancreatography. There was no consensus on the need for EUS fine-needle aspiration to evaluate cysts. There was disagreement on optimal screening modalities and intervals for follow-up imaging. When surgery is recommended it should be performed at a high-volume centre. There was great disagreement as to which screening abnormalities were of sufficient concern to for surgery to be recommended. Conclusions: Screening is recommended for high-risk individuals, but more evidence is needed, particularly for how to manage patients with detected lesions. Screening and subsequent management should take place at high-volume centres with multidisciplinary teams, preferably within research protocols.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Pancreas surveillance has been recommended for individuals estimated to be at high risk of developing PDAC (5% or higher estimated lifetime risk).5-8”
From The Multicenter Cancer of Pancreas Screening Study: Impact on Stage and Survival (2022) · cites this paper as [5]
In the citing paper
“The US Preventive Services Task Force and other guidelines recommend against screening for pancreatic ductal adenocarcinoma in asymptomatic adults at average risk.6,53,54”
From Early detection of pancreatic cancer (2020) · cites this paper as [6]
In the citing paper
“All screening programmes for pancreatic ductal adenocarcinoma aim to detect and treat T1N0M0 cancers or high-grade dysplastic premalignant lesions (ie, pancreatic intraepithelial neoplasia 3 or mucinous cystic tumours with high-grade dysplasia).6,54”
From Early detection of pancreatic cancer (2020) · cites this paper as [6]
In the citing paper
“This target includes individuals with at least two first-degree relatives with pancreatic ductal adenocarcinoma, patients with hereditary pancreatitis or particular genetic syndromes (eg, Peutz-Jeghers syndrome, or germline mutations in the CDKN2A, BRCA2, or PALB2),6,54 and individuals with mucinous cystic lesions of the pancreas.19–21”
From Early detection of pancreatic cancer (2020) · cites this paper as [6]
In the citing paper
“However, international guidelines and a white paper on the early detection of pancreatic ductal adenocarcinoma recommend targeted screening of individuals whose lifetime risk of developing pancreatic ductal adenocarcinoma is higher than 5% (figure 1).6,54”
From Early detection of pancreatic cancer (2020) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Ferlay, J., Ward, E., & Forman, D. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 55,077
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths
Zauber, A. G., Winawer, S. J., O’Brien, M. J., Lansdorp‐Vogelaar, I., van Ballegooijen, M., Hankey, B. F., Shi, W., Bond, J. H., Schapiro, M., Panish, J. F., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1100370 · Cited by 3,185
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., et al. (2010) · Nature · doi:10.1038/nature09515 · Cited by 2,502
Self-citationInternational consensus guidelines 2012 for the management of IPMN and MCN of the pancreas
Tanaka, M., Fernández-del Castillo, C., Adsay, V., Chari, S., Falconi, M., Jang, J.-Y., Kimura, W., Levy, P., Pitman, M. B., Schmidt, C. M., et al. (2012) · Pancreatology · doi:10.1016/j.pan.2012.04.004 · Cited by 2,354
Tanaka, M., Chari, S. T., Adsay, V. N., Carlos, F.-D., Falconi, M., Shimizu, M., Yamaguchi, K., Yamao, K., & Matsuno, S. (2005) · Pancreatology · doi:10.1159/000090023 · Cited by 2,042
An Assessment of Clinically Useful Measures of the Consequences of Treatment
Laupacis, A., Sackett, D. L., & Roberts, R. S. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806303182605 · Cited by 1,681
1423 Pancreaticoduodenectomies for Pancreatic Cancer: A Single-Institution Experience
Winter, J. M., Cameron, J. L., Campbell, K. A., Arnold, M. A., Chang, D. C., Coleman, J., Hodgin, M. B., Sauter, P. K., Hruban, R. H., Riall, T. S., et al. (2006) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2006.08.018 · Cited by 1,491
Self-citationVery high risk of cancer in familial Peutz–Jeghers syndrome
Giardiello, F. M., Brensinger, J. D., Tersmette, A. C., Goodman, S. N., Petersen, G. M., Booker, S. V., Cruz–Correa, M., & Offerhaus, G. J. A. (2000) · Gastroenterology · doi:10.1053/gast.2000.20228 · Cited by 1,435
Self-citation
Cited by
Sorted by citations
Mizrahi, J. D., Surana, R., Valle, J. W., & Shroff, R. T. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30974-0 · Cited by 2,559
Ryan, D. P., Hong, T. S., & Bardeesy, N. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1404198 · Cited by 2,348
Kamisawa, T., Wood, L. D., Itoi, T., & Takaori, K. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00141-0 · Cited by 2,212
Kleeff, J., Korc, M., Apte, M., La Vecchia, C., Johnson, C. D., Biankin, A. V., Neale, R. E., Tempero, M., Tuveson, D. A., Hruban, R. H., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.22 · Cited by 1,982
Self-citationPancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes
McGuigan, A. J., Kelly, P. J., Turkington, R. C., Jones, C. A., Coleman, H. G., & McCain, R. S. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i43.4846 · Cited by 1,934
Syngal, S., Brand, R. E., Church, J. M., Giardiello, F. M., Hampel, H. L., & Burt, R. W. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.435 · Cited by 1,662
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A. E., ELIAS, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,612
European evidence-based guidelines on pancreatic cystic neoplasms
The European Study Group on Cystic Tumours of the Pancreas (2018) · Gut · doi:10.1136/gutjnl-2018-316027 · Cited by 1,417
Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors
Klein, A. P. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00457-x · Cited by 1,258
Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
Tempero, M. A., Malafa, M. P., Al-Hawary, M. M., Asbun, H. J., Bain, A. J., Behrman, S. W., Benson, A. B., Binder, E. F., Cardin, D. B., Cha, C. H., et al. (2017) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2017.0131 · Cited by 1,037
Molecular subtypes of pancreatic cancer
Collisson, E. A., Bailey, P., Chang, D. K., & Biankin, A. V. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0109-y · Cited by 892
Recent progress in pancreatic cancer
Wolfgang, C. L., Herman, J. M., Laheru, D. A., Klein, A. P., Erdek, M. A., Fishman, E. K., & Hruban, R. H. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21190 · Cited by 935
Self-citationHu, C., Hart, S. N., Polley, E. C., Gnanaolivu, R., Shimelis, H., Lee, K. Y., Lilyquist, J., Na, J., Moore, R., Antwi, S. O., et al. (2018) · JAMA · doi:10.1001/jama.2018.6228 · Cited by 577
Challenges in diagnosis of pancreatic cancer
Zhang, L., Sanagapalli, S., & Stoita, A. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i19.2047 · Cited by 600
Giardiello, F. M., Allen, J. I., Axilbund, J. E., Boland, C. R., Burke, C. A., Burt, R. W., Church, J. M., Dominitz, J. A., Johnson, D. A., Kaltenbach, T. R., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.04.001 · Cited by 559
Ohtsuka, T., Castillo, C. F. F.-D., Furukawa, T., Hijioka, S., Jang, J., Lennon, A. M., Miyasaka, Y., Ohno, E., Salvia, R., Wolfgang, C. L., et al. (2023) · Pancreatology · doi:10.1016/j.pan.2023.12.009 · Cited by 550
Genetics and biology of pancreatic ductal adenocarcinoma
Ying, H., Dey, P., Yao, W., Kimmelman, A. C., Draetta, G. F., Maitra, A., & DePinho, R. A. (2016) · Genes & Development · doi:10.1101/gad.275776.115 · Cited by 527
Stoffel, E. M., Brand, R. E., & Goggins, M. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.02.012 · Cited by 565
Self-citationCancers associated with BRCA 1 and BRCA 2 mutations other than breast and ovarian
Mersch, J. A., Jackson, M., Park, M., Nebgen, D. R., Peterson, S. K., Singletary, C. N., Arun, B., & Litton, J. K. (2014) · Cancer · doi:10.1002/cncr.29041 · Cited by 513
Monahan, K. J., Bradshaw, N., Dolwani, S., DeSouza, B., Dunlop, M. G., East, J. E., Ilyas, M., Kaur, A., Lalloo, F. I., Latchford, A. R., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-319915 · Cited by 504
Giardiello, F. M., Allen, J. I., Axilbund, J. E., Boland, C. R., Burke, C. A., Burt, R. W., Church, J. M., Dominitz, J. A., Johnson, D. A., Kaltenbach, T. R., et al. (2014) · The American Journal of Gastroenterology · doi:10.1038/ajg.2014.186 · Cited by 483
Early detection of pancreatic cancer
Pereira, S. P., Oldfield, L., Ney, A., Hart, P. A., Keane, M. G., Pandol, S. J., Li, D., Greenhalf, W., Jeon, C. Y., Koay, E. J., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30416-9 · Cited by 482
Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis
Cai, J., Chen, H., Lu, M., Zhang, Y., Lu, B., You, L., Zhang, T., Dai, M., & Zhao, Y. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.06.027 · Cited by 495
Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification
Kamps, R., Brandão, R. D., van den Bosch, B. J. C., Paulussen, A. D. C., Xanthoulea, S., Blok, M. J., & Romano, A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020308 · Cited by 472
Risk factors for pancreatic cancer: a summary review of meta-analytical studies
Maisonneuve, P., & Lowenfels, A. B. (2014) · International Journal of Epidemiology · doi:10.1093/ije/dyu240 · Cited by 465
Tung, N., Battelli, C., Allen, B. A., Kaldate, R., Bhatnagar, S., Bowles, K. R., Timms, K. M., Garber, J. E., Herold, C. I., Ellisen, L. W., et al. (2014) · Cancer · doi:10.1002/cncr.29010 · Cited by 442
Canto, M. I., Almario, J. A., Schulick, R. D., Yeo, C. J., Klein, A., Blackford, A., Shin, E. J., Sanyal, A., Yenokyan, G., Lennon, A. M., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.05.035 · Cited by 414
Self-citationPaluch–Shimon, S., Cardoso, F., Sessa, C., Balmañà, J., Cardoso, M. J., Gilbert, F. J., & Senkus, E. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw327 · Cited by 400
Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma
Holter, S., Borgida, A., Dodd, A., Grant, R., Semotiuk, K., Hedley, D., Dhani, N., Narod, S., Akbari, M., Moore, M., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.7401 · Cited by 398
Pancreatic Cancer: Yesterday, Today and Tomorrow
Ansari, D., Tingstedt, B., Andersson, B., Holmquist, F., Sturesson, C., Williamsson, C., Sasor, A., Borg, D., Bauden, M. P., & Andersson, R. E. (2016) · Future Oncology · doi:10.2217/fon-2016-0010 · Cited by 399
Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer
Roberts, N. J., Norris, A. L., Petersen, G. M., Bondy, M. L., Brand, R., Gallinger, S., Kurtz, R. C., Olson, S. H., Rustgi, A. K., Schwartz, A. G., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0402 · Cited by 361
Self-citationEarly screening and diagnosis strategies of pancreatic cancer: a comprehensive review
Yang, J., Xu, R., Wang, C., Qiu, J., Ren, B., & You, L. (2021) · Cancer Communications · doi:10.1002/cac2.12204 · Cited by 379
CA 19-9: Biochemical and Clinical Aspects
Scarà, S., Bottoni, P., & Scatena, R. (2015) · Advances in Experimental Medicine and Biology · doi:10.1007/978-94-017-7215-0_15 · Cited by 351
Vasen, H., Ibrahim, I., Ponce, C. G., Slater, E. P., Matthäi, E., Carrato, A., Earl, J., Robbers, K., van Mil, A. M., Potjer, T., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.0730 · Cited by 344
Cancer overdiagnosis: a biological challenge and clinical dilemma
Srivastava, S., Koay, E. J., Borowsky, A. D., Marzo, A. M. D., Ghosh, S., Wagner, P. D., & Kramer, B. S. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0142-8 · Cited by 349
Pancreatic ductal adenocarcinoma: Risk factors, screening, and early detection
Becker, A. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i32.11182 · Cited by 357
AGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals: Expert Review
Aslanian, H. R., Lee, J. H., & Canto, M. I. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.03.088 · Cited by 317
Self-citationMayerle, J. V., Kalthoff, H., Reszka, R. C., Kamlage, B., Peter, E., Schniewind, B., Maldonado, S. G., Pilarsky, C. P., Heidecke, C.-D., Schatz, P., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-312432 · Cited by 310
BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study
Zhen, D. B., Rabe, K. G., Gallinger, S., Syngal, S., Schwartz, A. G., Goggins, M. G., Hruban, R. H., Cote, M. L., McWilliams, R. R., Roberts, N. J., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2014.153 · Cited by 295
Self-citationDiagnosis and Detection of Pancreatic Cancer
Chu, L. C. H., Goggins, M., & Fishman, E. K. (2017) · The Cancer Journal · doi:10.1097/ppo.0000000000000290 · Cited by 304
Self-citationLi, A., Yu, J., Kim, H., Wolfgang, C. L., Canto, M. I., Hruban, R. H., & Goggins, M. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3092 · Cited by 295
Self-citationBurden of Pancreatic Cancer: From Epidemiology to Practice
Khalaf, N., El-Serag, H. B., Abrams, H. R., & Thrift, A. P. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.02.054 · Cited by 308
Current status and progress of pancreatic cancer in China
Lin, Q. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i26.7988 · Cited by 285
Blackford, A. L., Canto, M. I., Klein, A. P., Hruban, R. H., & Goggins, M. (2020) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djaa004 · Cited by 270
Self-citationCarreras‐Torres, R., Johansson, M., Gaborieau, V., Haycock, P., Wade, K. H., Relton, C. L., Martin, R. M., Smith, G. D., & Brennan, P. (2017) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx012 · Cited by 273
Lennon, A. M., Wolfgang, C. L., Canto, M. I., Klein, A. P., Herman, J. M., Goggins, M., Fishman, E. K., Kamel, I. R., Weiss, M. J., Diaz, L. A., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0734 · Cited by 268
Self-citationStjepanovic, N., Moreira, L., Carneiro, F., Balaguer, F., Cervantes, A. M. R., Balmañà, J., & Martinelli, E. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz233 · Cited by 253
The Multicenter Cancer of Pancreas Screening Study: Impact on Stage and Survival
Dbouk, M., Katona, B. W., Brand, R. E., Chak, A., Syngal, S., Farrell, J. J., Kastrinos, F., Stoffel, E. M., Blackford, A. L., Rustgi, A. K., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.22.00298 · Cited by 247
Self-citationHereditary melanoma: Update on syndromes and management
Soura, E., Eliades, P. J., Shannon, K., Stratigos, A., & Tsao, H. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.08.038 · Cited by 230
Huang, L., Jansen, L., Balavarca, Y., Molina‐Montes, E., Babaei, M., van der Geest, L. G., Lemmens, V. E. P. P., Eycken, L. J. V., Schutter, H. D., Johannesen, T. B., et al. (2017) · Gut · doi:10.1136/gutjnl-2017-314828 · Cited by 231
Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages
Yu, J., Blackford, A. L., dal Molin, M., Wolfgang, C. L., & Goggins, M. (2015) · Gut · doi:10.1136/gutjnl-2014-308653 · Cited by 224
Self-citationIdentification of a three-biomarker panel in urine for early detection of pancreatic adenocarcinoma
Radon, T. P., Massat, N. J., Jones, R., Alrawashdeh, W., Dumartin, L., Ennis, D., Duffy, S. W., Kocher, H. M., Pereira, S. P., Guarner (posthumous), L., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2467 · Cited by 203
Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion
Stoffel, E. M., McKernin, S. E., Brand, R. E., Canto, M. I., Goggins, M., Moravek, C., Nagarajan, A., Petersen, G. M., Simeone, D. M., Yurgelun, M. B. B., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.18.01489 · Cited by 205
Self-citationNeuzillet, C., Gaujoux, S., Williet, N., Bachet, J., Bauguion, L., Durand, L. C., Conroy, T., Dahan, L., Gilabert, M., Huguet, F., et al. (2018) · Digestive and Liver Disease · doi:10.1016/j.dld.2018.08.008 · Cited by 222
Aleissa, M. A., Lerner, L., Abdelfatah, E., Shankar, N., Canner, J. K., Hasan, N. M., Yaghoobi, V., Huang, B., Kerner, Z. J., Takaesu, F., et al. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0650-0 · Cited by 196
Self-citationSăftoiu, A., Hassan, C., Areia, M., Bhutani, M., Bisschops, R., Bories, E., Cazacu, I., Dekker, E., Deprez, P., Pereira, S., et al. (2020) · Endoscopy · doi:10.1055/a-1104-5245 · Cited by 187
Giri, V. N., Knudsen, K. E., Kelly, W. K., Abida, W. M., Andriole, G. L., Bangma, C. H., Bekelman, J. E., Benson, M. C., Blanco, A. M., Burnett, A. L. “., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.1173 · Cited by 193
Hereditary Colorectal Polyposis and Cancer Syndromes: A Primer on Diagnosis and Management
Kanth, P., Grimmett, J., Champine, M., Burt, R. W., & Samadder, J. N. (2017) · The American Journal of Gastroenterology · doi:10.1038/ajg.2017.212 · Cited by 186
Pancreatic Cancer Surveillance and Survival of High-Risk Individuals
Blackford, A. L., Canto, M. I., Dbouk, M. H., Hruban, R. H., Katona, B. W., Chak, A., Brand, R. E., Syngal, S., Farrell, J. J., Kastrinos, F., et al. (2024) · JAMA Oncology · doi:10.1001/jamaoncol.2024.1930 · Cited by 178
Self-citationHall, M. J., Bernhisel, R., Hughes, E., Larson, K., Rosenthal, E. T., Singh, N. A., Lancaster, J. M., & Kurian, A. W. (2021) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-20-0448 · Cited by 173
Yu, J., Sadakari, Y., Shindo, K., Suenaga, M., Brant, A., Almario, J. A. N., Borges, M., Barkley, T., Fesharakizadeh, S., Ford, M., et al. (2017) · Gut · doi:10.1136/gutjnl-2015-311166 · Cited by 164
Self-citationHarinck, F., Konings, I. C. A. W., Kluijt, I., Poley, J. W., van Hooft, J. E., van Dullemen, H. M., Nio, C. Y., Krak, N. C., Hermans, J. J., Aalfs, C. M., et al. (2016) · Gut · doi:10.1136/gutjnl-2014-308008 · Cited by 185
Self-citationArtificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review
Kenner, B., Chari, S. T., Kelsen, D., Klimstra, D. S., Pandol, S. J., Rosenthal, M., Rustgi, A. K., Taylor, J. A., Yala, A., Abul-Husn, N., et al. (2021) · Pancreas · doi:10.1097/mpa.0000000000001762 · Cited by 158
Self-citationPetersen, G. M. (2016) · Seminars in Oncology · doi:10.1053/j.seminoncol.2016.09.002 · Cited by 157
Sawhney, M., Calderwood, A. H., Thosani, N. C., Rebbeck, T. R., Wani, S. B., Canto, M. I., Fishman, D. S., Golan, T., Hidalgo, M. M., Kwon, R. S., et al. (2022) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2021.12.001 · Cited by 158
Self-citationDiabetes, weight change, and pancreatic cancer risk
Yuan, C., Babic, A., Khalaf, N., Nowak, J. A., Brais, L. K., Rubinson, D. A., Ng, K., Aguirre, A. J., Pandharipande, P. V., Fuchs, C. S., et al. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.2948 · Cited by 150
The Management of Peutz–Jeghers Syndrome: European Hereditary Tumour Group (EHTG) Guideline
Wagner, A., Aretz, S., Auranen, A., Bruno, M. J., Cavestro, G. M., Crosbie, E. J., Goverde, A., Jelsig, A. M., Latchford, A. R., van Leerdam, M. E., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030473 · Cited by 151
Self-citationEarly detection and prevention of pancreatic cancer: Is it really possible today?
Chiaro, M. D. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i34.12118 · Cited by 135
Identification, genetic testing, and management of hereditary melanoma
Leachman, S. A., Lucero, O. M., Sampson, J. E., Cassidy, P. B., Bruno, W., Queirolo, P., & Ghiorzo, P. (2017) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9661-5 · Cited by 141
Pancreatitis-Diabetes-Pancreatic Cancer
Andersen, D. K., Andrén‐Sandberg, Å., Duell, E. J., Goggins, M., Korc, M., Petersen, G. M., Smith, J. P., & Whitcomb, D. C. (2013) · Pancreas · doi:10.1097/mpa.0b013e3182a9ad9d · Cited by 132
Self-citationSurgical and molecular pathology of pancreatic neoplasms
Hackeng, W. M., Hruban, R. H., Offerhaus, G. J. A., & Brosens, L. A. A. (2016) · Diagnostic Pathology · doi:10.1186/s13000-016-0497-z · Cited by 133
Self-citationKempeneers, M. A., Issa, Y., Ali, U. A., Baron, R. D., Besselink, M. G., Büchler, M. W., Erkan, M., Castillo, C. F. F.-D., Isaji, S., Izbicki, J. R., et al. (2019) · Pancreatology · doi:10.1016/j.pan.2019.12.005 · Cited by 127
Epidemiology and burden of pancreatic cancer
Maisonneuve, P. (2019) · La Presse Médicale · doi:10.1016/j.lpm.2019.02.030 · Cited by 124
Pancreatic cancer surgery: past, present, and future.
Griffin, J. F., Poruk, K. E., & Wolfgang, C. L. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.1000-9604.2015.06.07 · Cited by 130
Diagnostic strategies for early pancreatic cancer
Hanada, K., Okazaki, A., Hirano, N., Izumi, Y., Teraoka, Y., Ikemoto, J., Kanemitsu, K., Hino, F., Fukuda, T., & Yonehara, S. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-014-1026-z · Cited by 121
Prognostic and predictive markers in pancreatic adenocarcinoma
Le, N. N. H., Sund, M., Vinci, A., Beyer, G., Javed, M., Krug, S., Neessee, A., & Schober, M. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.11.001 · Cited by 122
A Multidisciplinary Approach to Pancreas Cancer in 2016: A Review
Fogel, E. L., Shahda, S., Sandrasegaran, K., DeWitt, J. M., Easler, J. J., Agarwal, D. M., Eagleson, M. A., Zyromski, N. J., House, M. G., Ellsworth, S. G., et al. (2017) · The American Journal of Gastroenterology · doi:10.1038/ajg.2016.610 · Cited by 122
Korsse, S. E., Harinck, F., van Lier, M. G., Biermann, K., Offerhaus, G. J. A., Krak, N. C., Looman, C. W. N., van Veelen, W., Kuipers, E. J., Wagner, A., et al. (2012) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101277 · Cited by 118
Self-citationO'Reilly, D. A., Fou, L., Hasler, E., Hawkins, J. E., O'Connell, S. M., Pelone, F., Callaway, M. P., Campbell, F., Capel, M. M., Charnley, R., et al. (2018) · Pancreatology · doi:10.1016/j.pan.2018.09.012 · Cited by 120
Slavin, T. P., Niell‐Swiller, M., Solomon, I. B., Nehoray, B., Rybak, C., Blazer, K. R., & Weitzel, J. N. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00208 · Cited by 118
Homologous Recombination Deficiencies and Hereditary Tumors
Yamamoto, H., & Hirasawa, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010348 · Cited by 128
Overbeek, K. A., Goggins, M. G., Dbouk, M., Levink, I. J. M., Koopmann, B. D. M., Chuidian, M., Konings, I. C. A. W., Paiella, S., Earl, J., Fockens, P., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2021.10.014 · Cited by 114
Self-citationCorral, J. E., Mareth, K. F., Riegert-Johnson, D. L., Das, A., & Wallace, M. B. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.04.065 · Cited by 113
Familial Melanoma: Diagnostic and Management Implications
Rossi, M., Pellegrini, C., Cardelli, L., Ciciarelli, V., Nardo, L. D., & Fargnoli, M. C. (2019) · Dermatology Practical & Conceptual · doi:10.5826/dpc.0901a03 · Cited by 110
Familial pancreatic cancer: Concept, management and issues
Matsubayashi, H., Takaori, K., Morizane, C., Maguchi, H., Mizuma, M., Takahashi, H., Wada, K., Hosoi, H., Yachida, S., Suzuki, M., et al. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i6.935 · Cited by 109
BRCA Mutations in Pancreas Cancer: Spectrum, Current Management, Challenges and Future Prospects
Wong, W., Raufi, A. G., Safyan, R. A., Bates, S. E., & Manji, G. A. (2020) · Cancer Management and Research · doi:10.2147/cmar.s211151 · Cited by 114
The Role of BRCA Testing in Hereditary Pancreatic and Prostate Cancer Families
Pilarski, R. (2019) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_238977 · Cited by 115
State of the art and future directions of pancreatic ductal adenocarcinoma therapy
Neuzillet, C., Tijeras‐Raballand, A., Bourget, P., Cros, J. F., Couvelard, A., Sauvanet, A., Vullierme, M., Tournigand, C., & Hammel, P. R. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.08.006 · Cited by 114
Non-invasive biomarkers in pancreatic cancer diagnosis: what we need versus what we have
Herreros‐Villanueva, M., & Bujanda, L. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.03.44 · Cited by 102
Abe, T., Blackford, A. L., Tamura, K., Ford, M., McCormick, P., Chuidian, M., Almario, J. A., Borges, M., Lennon, A. M., Shin, E. J., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.01512 · Cited by 102
Self-citationBeyer, G., Hoffmeister, A., Michl, P., Gress, T. M., Huber, W., Algül, H., Neeße, A., Meining, A. G., Seufferlein, T. T. W., Rosendahl, J., et al. (2022) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1735-3864 · Cited by 108
Genetic predisposition to pancreatic cancer
Ghiorzo, P. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i31.10778 · Cited by 109
Familial pancreatic cancer: genetic advancesPreprint
Rustgi, A. K. (2014) · Genes & Development · doi:10.1101/gad.228452.113 · Cited by 101
Advances in Pancreatic CT Imaging
de Almeida, R. R., Lo, G. C., Patiño, M., Bizzo, B. C., Canellas, R., & Sahani, D. V. (2018) · American Journal of Roentgenology · doi:10.2214/ajr.17.18665 · Cited by 99
Mutations in the pancreatic secretory enzymes CPA1 and CPB1 are associated with pancreatic cancer
Tamura, K., Yu, J., Hata, T., Suenaga, M., Shindo, K., Abe, T., MacGregor-Das, A., Borges, M., Wolfgang, C. L., Weiss, M. J., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1720588115 · Cited by 95
Self-citationA protein corona-enabled blood test for early cancer detection
Caputo, D. D., Papi, M., Coppola, R., Palchetti, S., Digiacomo, L., Caracciolo, G., & Pozzi, D. (2016) · Nanoscale · doi:10.1039/c6nr05609a · Cited by 96
Chiaro, M. D., Beckman, R. M., Ateeb, Z., Orsini, N., Rezaee, N., Manos, L. L., Valente, R., Yuan, C., Ding, D., Margonis, G. A., et al. (2019) · Annals of Surgery · doi:10.1097/sla.0000000000003174 · Cited by 96
Chiaro, M. D., Verbeke, C. S., Kartalis, N., Mucelli, R. P., Gustafsson, P., Hansson, J., Haas, S., Segersvärd, R., Andrén‐Sandberg, Å., & Löhr, M. J. (2015) · JAMA Surgery · doi:10.1001/jamasurg.2014.3852 · Cited by 92
Early onset pancreatic cancer: Risk factors, presentation and outcome
Piciucchi, M., Capurso, G., Valente, R., Larghi, A., Archibugi, L., Signoretti, M., Stigliano, S., Zerboni, G., Barucca, V., Torre, M. L., et al. (2015) · Pancreatology · doi:10.1016/j.pan.2015.01.013 · Cited by 92
Identification and management of pancreas divisum
Gutta, A., Fogel, E. L., & Sherman, S. (2019) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2019.1685871 · Cited by 92
Metadata
- Authors
- Canto, M. I., Harinck, F., Hruban, R. H., Offerhaus, G. J., Poley, J.-W., Kamel, I., Nio, Y., Schulick, R. S., Bassi, C., Kluijt, I., Levy, M. J., Chak, A., Fockens, P., Goggins, M., & Bruno, M.
- Affiliations
- Johns Hopkins University (US)
- Erasmus MC (NL)
- Utrecht University (NL)
- Department of Radiology, Academic Medical Center, Amsterdam, The Netherlands
- Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
- University of Verona (IT)
- Amsterdam UMC Location University of Amsterdam (NL)
- Mayo Clinic (US)
- University Hospitals of Cleveland (US)
- Corresponding author
- Canto, Marcia Irene
- ORCID
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2012-11-07
- Volume
- 62
- Issue
- 3
- Pages
- 339-347
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- PMC
- PMC3585492
- OpenAlex
- W2111705409
- Cited by
- 784
- References
- 88
- Citations by year
- 2026: 23 · 2025: 23 · 2024: 40 · 2023: 53 · 2022: 66 · 2021: 73 · 2020: 61 · 2019: 82 · 2018: 82 · 2017: 67 · 2016: 71 · 2015: 69 · 2014: 45 · 2013: 23 · 2012: 6
- FWCI
- 22.79
- Type
- journal article
- Language
- en
- Update notices
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Gut (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
- Utrecht University Repository (Utrecht University) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Leiden Repository (Leiden University) (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- National Cancer Institute (K24CA113433, P30CA006973)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- pancreatic cancer screening, familial pancreatic cancer, genetic susceptibility, pancreatic intraepithelial neoplasia, intraductal papillary mucinous neoplasm, Peutz-Jeghers syndrome, BRCA2 mutation carriers, Lynch syndrome, endoscopic ultrasound, surveillance interval, surgical management, high-volume centers, multidisciplinary team, consensus recommendations
- MeSH terms
- Age Factors, Carcinoma, Follow-Up Studies, Humans, Mutation, Pancreatectomy, Pancreatic Neoplasms, Pedigree, Risk Factors, Treatment Outcome, Endosonography, Genetic Predisposition to Disease, Cholangiopancreatography, Magnetic Resonance, Early Detection of Cancer, Neoplasm Grading
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
